Father of Exactech Employee Receives First Ankle Replacement Using Activit-E™ Polyethylene

Our Bureau

Exactech Quality Control Manager Wesley Garrett experienced a full circle moment in both his professional and personal life when his father received an Activit-E™ polyethylene insert after following the company’s polyethylene initiatives for six years.  In 2018, Garrett was hired as an intern to perform wear-testing for the company’s hip product line. Specifically, he […]

Innovent Announces First Participant Dosed in a Phase I Study of IBI3002 (an anti-IL-4Rα/TSLP bispecific antibody) in Australia 

Our Bureau

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major diseases, announces that the first participant has been dosed in Australia in a first-in-human (FIH) phase 1 clinical trial of IBI3002, a global first-in-class bispecific antibody targeting […]

Therap Services Debuts Secure Document Signing Module (SDS) with Enhanced Digital Security and Efficiency in Streamlining Healthcare Signatures

Our Bureau

Therap Services, the national leader in providing HIPAA-compliant electronic documentation solutions to organizations and caregivers in the Long-Term Services and Supports (LTSS), Home and Community-Based Services (HCBS) and broader human services setting, is excited to announce the launch of its new Secure Document Signing Module (SDS). This cutting-edge module is […]

Koning Health Achieves UAE Regulatory Clearance, Paving the Way for Breast CT Commercialization in the Middle East

Our Bureau

Koning Health, a pioneering medical imaging company, is thrilled to announce that it has received regulatory clearance from the Federal Authority for Nuclear Regulation (FANR) in the United Arab Emirates (UAE), marking a significant milestone in the company’s expansion and its commitment to global health innovation. The clearance process was a testament […]

Femasys’ FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVF

Our Bureau

Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting the significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead, late-clinical stage product candidate and innovative therapeutic and diagnostic products, today highlighted that its FemaSeed intratubal insemination product, a revolutionary approach to […]

Philips extends leadership in virtually helium-free MRI with more than 1,000 systems installed, expanding patient access worldwide

Our Bureau

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a significant milestone as it expands access to virtually helium-free [1] MRI to more patients in more places, with more than 1,000 systems now installed worldwide. As healthcare providers strive to deliver high-quality care to patients, at #ECR2024 Philips […]

Applied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic Galactosemia

Our Bureau

Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that the U.S. Food and Drug Administration (FDA) has accepted the filing of the New Drug Application (NDA) for govorestat (AT-007) […]

Tonix Pharmaceuticals Completes Clinical Stage of Phase 1 Trial for TNX-1500 (Fc-modified humanized anti-CD40L mAb) in Healthy Volunteers

Our Bureau

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, today announced the completion of the clinical stage of its Phase 1, single ascending dose escalation trial of TNX-1500 (Fc-modified humanized anti-CD40L monoclonal antibody, or mAb)* in healthy volunteers. TNX-1500 is in […]

Subscribe Now